Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Felder

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
FEBS Letters|September 16, 1996
Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and ratC C Felder, A Nielsen, E M Briley, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 22, 1998
LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulationC C Felder, K E Joyce, E M Briley, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2005
Identification of a high-affinity binding site involved in the transport of endocannabinoidsS A Moore, G G Nomikos, A K Dickason-Chesterfield, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 5, 2014
M1 and m2 muscarinic receptor subtypes regulate antidepressant-like effects of the rapidly acting antidepressant scopolamineJ M Witkin, C Overshiner, X Li, et al.
International Journal of Geriatric Psychiatry|December 19, 2001
A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical dataJ S Kennedy, F P Bymaster, L Schuh, et al.
Journal of Medicinal Chemistry|June 4, 1999
1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M1 agonists: structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivativesL Jeppesen, P H Olesen, L Hansen, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
FEBS Letters|September 16, 1996
Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and ratC C Felder, A Nielsen, E M Briley, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 22, 1998
LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulationC C Felder, K E Joyce, E M Briley, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2005
Identification of a high-affinity binding site involved in the transport of endocannabinoidsS A Moore, G G Nomikos, A K Dickason-Chesterfield, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 5, 2014
M1 and m2 muscarinic receptor subtypes regulate antidepressant-like effects of the rapidly acting antidepressant scopolamineJ M Witkin, C Overshiner, X Li, et al.
International Journal of Geriatric Psychiatry|December 19, 2001
A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical dataJ S Kennedy, F P Bymaster, L Schuh, et al.
Journal of Medicinal Chemistry|June 4, 1999
1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M1 agonists: structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivativesL Jeppesen, P H Olesen, L Hansen, et al.
Pageof 8